FB2026_01 , released March 12, 2026
FB2026_01 , released March 12, 2026
Human Disease Model Report: Yoon-Bellen neurodevelopmental syndrome
Open Close
General Information
Name
Yoon-Bellen neurodevelopmental syndrome
FlyBase ID
FBhh0000719
Disease Ontology Term
Parent Disease
Overview

Based on phenotypic findings in Drosophila and on experiments showing that the Drosophila orthologs of NRDC and OGDH/OGDHL interact, the BHCMG database was used to identify individuals carrying variants of OGDH or OGDHL. (See neurodegenerative disease, NRDC-related, FBhh0000718.) A missense mutation in the human OGDHL gene emerged as a top candidate for implication in a syndrome of severe developmental delay with cerebral and cerebellar atrophy and corpus callosum abnormality. Subsequently, additional cases have been identified; this disease exhibits autosomal recessive inheritance.

OGDHL is a paralog of OGDH, oxoglutarate dehydrogenase, a subunit of the 2-oxoglutarate dehydrogenase complex, which participates in the citric acid (TCA) cycle in the mitochondrial matrix. There are two Drosophila orthologs of OGDH and OGDHL, Ogdh and CG33791, for which RNAi targeting constructs and alleles caused by insertional mutagenesis have been generated. For Ogdh, there is also a loss-of-function allele created by insertion of a T24-GAL4 driver construct that also results in Ogdh-relevant stage- and tissue-specific expression of the driver.

Multiple UAS constructs of the human gene Hsap\OGDHL, have been introduced into flies, including wild-type and OGDHL variants implicated in this human disease. Partial heterologous rescue (functional complementation) has been demonstrated: for neurophysiology defective phenotypes of Dmel\Ogdh, rescue is observed when wild-type Hsap\OGDHL is co-expressed.

Multiple variants implicated in this disease have been assessed using transgenic constructs of the human gene and analogous mutations in fly gene; see the 'Disease-Implicated Variants' table, below. Variants have been assessed for ability to rescue the lethal and neurophysiology phenotypes of Dmel\Ogdh.

A severe loss-of-function mutation of Dmel\Ogdh causes lethality and neurophysiology defects. Using an eye-specific driver, RNAi directed against Ogdh results in age-progressive loss of synaptic transmission in photoreceptor cells. Physical interactions of Dmel\Ogdh have been described; see below and in the Ogdh gene report.

Work in Drosophila has contributed to the characterization of NRDC as a mitochondrial chaperone or co-chaperone for OGDH (see the human disease model report 'neurodegenerative disease, NRDC-related' FBhh0000718). See also the human disease model report 'oxoglutarate dehydrogenase deficiency' (FBhh0001423).

[updated Jan. 2022 by FlyBase; FBrf0222196]

Disease Summary Information
Disease Summary: Yoon-Bellen neurodevelopmental syndrome
OMIM report
Human gene(s) implicated
Symptoms and phenotype

A range of neurological and neurodevelopmental phenotypes are observed including epilepsy, hearing loss, visual impairment, gait ataxia, microcephaly, and hypoplastic corpus callosum (Yap et al., 2021; pubmed:34800363; FBrf0252033).

Yoon-Bellen neurodevelopmental syndrome (YOBELN) is an autosomal recessive disorder characterized mainly by global developmental delay with variably impaired intellectual development. The manifestations and severity of the phenotype are highly variable. Additional neurologic features may include hypotonia, spasticity, ataxia, hearing loss, visual problems, seizures, and nonspecific anomalies on brain imaging (summary by Yap et al., 2021; pubmed:34800363). [from MIM:619701; 2022.07.20]

Genetics

Based on an assessment of 9 individuals from 8 unrelated families, this disease exhibits autosomal recessive inheritance (Yap et al., 2021; pubmed:34800363; FBrf0252033).

Yoon-Bellen neurodevelopmental syndrome (YOBELN) is caused by homozygous or compound heterozygous mutation in the OGDHL gene. [from MIM:619701; 2022.07.20]

Cellular phenotype and pathology
Molecular information

OGDH and OGDHL are paralogous genes that share 77% identity and 87% similarity. [DIOPT; 2018.01.31]

OGDH encodes oxoglutarate dehydrogenase, one subunit of the 2-oxoglutarate dehydrogenase complex, which participates in the citric acid (TCA) cycle in the mitochondrial matrix. [from Gene Cards, OGDH, OGDHL; 2018.01.31]

OGDHL encodes a protein similar to oxoglutarate dehydrogenase (OGDH), a subunit of the 2-oxoglutarate dehydrogenase complex (OGDHC). The OGDHC functions primarily in the mitochondria, participating in the citric acid (TCA) cycle in the mitochondrial matrix. [from Gene Cards, OGDH, OGDHL; 2022.01.09]

OGDH and OGDHL are paralogous genes that share 77% identity and 87% similarity. [DIOPT; 2022.01.09]

External links
Disease synonyms
neurodegenerative disease, OGDHL-related
neurodegenerative disease, OGDH-related
YOBELN
Ortholog Information
Human gene(s) in FlyBase
Human gene (HGNC)
D. melanogaster ortholog (based on DIOPT)
Comments on ortholog(s)

Many to many: 2 human to 2 Drosophila; the other human gene is OGDH.

Other mammalian ortholog(s) used
    D. melanogaster Gene Information (1)
    Gene Snapshot
    Oxoglutarate dehydrogenase 1 (Ogdh1) encodes the E1 subunit of the mitochondrial oxoglutarate dehydrogenase complex that catalyzes the oxidative decarboxylation of 2-oxoglutarate to succinyl-CoA, NADH and CO2 in the fourth step of the tricarboxylic acid (TCA) cycle. Ogdh1 catalyzes the decarboxylation of 2-oxoglutarate by the thiamine pyrophosphate (TPP)-cofactor producing a 2-succinyl intermediate and CO2. [Date last reviewed: 2025-03-27]
    Gene Groups / Pathways
    Comments on ortholog(s)

    High-scoring ortholog of human OGDH and OGDHL (2 Drosophila to 2 human). Dmel\Ogdh shares 56-62% identity and 68-75% similarity with the human genes.

    Orthologs and Alignments from DRSC
    DIOPT - DRSC Integrative Ortholog Prediction Tool - Click the link below to search for orthologs in Humans
    Other Genes Used: Viral, Bacterial, Synthetic (0)
      Summary of Physical Interactions (20 groups)
      protein-protein
      Interacting group
      Assay
      References
      experimental knowledge based, anti tag coimmunoprecipitation, western blot
      experimental knowledge based
      anti tag coimmunoprecipitation, Identification by mass spectrometry
      experimental knowledge based
      experimental knowledge based
      experimental knowledge based
      anti tag coimmunoprecipitation, peptide massfingerprinting, experimental knowledge based
      experimental knowledge based
      experimental knowledge based
      experimental knowledge based
      experimental knowledge based
      experimental knowledge based
      anti tag coimmunoprecipitation, anti tag western blot, Identification by mass spectrometry
      anti tag coimmunoprecipitation, Identification by mass spectrometry
      experimental knowledge based
      anti tag coimmunoprecipitation, Identification by mass spectrometry
      experimental knowledge based
      experimental knowledge based
      experimental knowledge based
      two hybrid, bimolecular fluorescence complementation, fluorescence microscopy
      Alleles Reported to Model Human Disease (Disease Ontology) (17 alleles)
      Models Based on Experimental Evidence ( 17 )
      Allele
      Disease
      Evidence
      References
      Modifiers Based on Experimental Evidence ( 9 )
      Alleles Representing Disease-Implicated Variants
      Genetic Tools, Stocks and Reagents
      Sources of Stocks
      Contact lab of origin for a reagent not available from a public stock center.
      Bloomington Stock Center Disease Page
      Related mammalian, viral, bacterial, or synthetic transgenes
      Allele
      Transgene
      Publicly Available Stocks
      Selected Drosophila transgenes
      Allele
      Transgene
      Publicly Available Stocks
      RNAi constructs available
      Allele
      Transgene
      Publicly Available Stocks
      Selected Drosophila classical alleles
      Allele
      Allele class
      Mutagen
      Publicly Available Stocks
      References (13)